{"url_path":"/sec/okyo/10-k/2026/item-16c","section_key":"item-16c","section_title":"Item 16C PRINCIPAL ACCOUNTANT FEES AND SERVICES**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1849296/0001493152-26-033847-index.html","accession_number":"0001493152-26-033847","cik":"0001849296","ticker":"OKYO","issuer_name":"OKYO Pharma Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/1849296/0001493152-26-033847-index.html","primary_entity_key":"0001849296","primary_entity_name":"OKYO Pharma Ltd"},"word_count":108,"has_tables":true,"body_markdown":"**ITEM\n16C: PRINCIPAL ACCOUNTANT FEES AND SERVICES**\n\n \n\nThe\nfollowing table sets forth, for each of the years indicated, the aggregate fees billed to us for services rendered by PKF Littlejohn\nLLP, our independent registered public accounting firm and Mazars, our previous independent registered public accounting firm:\n\n \n\nPKF Littlejohn LLP \nYear Ended March 31, \n\n  \n2026  \n2025 \n\n  \n(in thousands) \n\nAudit fees \n 134  \n 134 \n\nOther assurance services(1) \n 31  \n 22 \n\n  \n    \n   \n\nTotal \n 165  \n 156 \n\n \n\nMazars LLP \nYear Ended March 31, \n\n  \n2026  \n2025 \n\n  \n(in thousands) \n\nAudit fees \n -  \n - \n\nOther assurance services(1) \n -  \n 27 \n\n  \n    \n   \n\nTotal \n -  \n 27 \n\n \n\n(1)\nOther assurance services\ninclude interim reviews, analyzing the processes, controls, and operations required for other filings"}